UBS’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-26,200
Closed -$3.27M 11384
2013
Q3
$3.27M Buy
26,200
+24,200
+1,210% +$3.06M ﹤0.01% 2100
2013
Q2
$174K Buy
+2,000
New +$184K ﹤0.01% 5257

UBS's ONXX Position: Q4 2013 in Review

UBS sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 108,654 shares — an estimated $13.5M sold.

UBS first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $13.5M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • UBS reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • UBS sold 108,654 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $13.5M.
  • UBS first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • UBS's ONYX PHARMACEUTICALS INC position peaked at $13.5M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.